The FDA is working to pull illegal products from the marketplace to protect public health, seeking to stop US sales of numerous products illegally marketed as diabetes treatments.
After deliberating, an FDA advisory panel voted to recommend the comprehensive and severe restrictions on Avandia (rosiglitazone) be changed.
A new study published in the Journal of the American Medical Association suggests that low levels of melatonin could increase the risk of developing type 2 diabetes.
receive the latest information about glucose
meters, diabetic supplies, and product offers
right to your inbox. Get started today.